Literature DB >> 30248060

Myotonic Dystrophy Type 2 - Data from the Serbian Registry.

Ivo Bozovic1, Stojan Peric1, Jovan Pesovic2, Bogdan Bjelica1, Milos Brkusanin2, Ivana Basta1, Marija Bozic3, Ivan Sencanic4, Ana Marjanovic1, Marija Brankovic1, Dusanka Savic-Pavicevic2, Vidosava Rakocevic-Stojanovic1.   

Abstract

BACKGROUND: Myotonic dystrophy type 2 (DM2) is a multisystem disorder, mostly presented with mild but heterogeneous spectrum of symptoms.
OBJECTIVE: The aim of this research was to provide detailed sociodemographic, clinical and laboratory data of a large DM2 cohort from the Serbian registry.
METHODS: In 2008, we started to prospectively enter data of all DM patients. We also retrospectively collected data of patients hospitalized from 1990 until 2008.
RESULTS: At the end of 2017, registry comprised 87 (68%) of 128 genetically confirmed DM2 patients in Serbia, i.e. 1.2 registered cases per 100,000 inhabitants. Female subjects were more prevalent (63%). The diagnostic delay was 11.8±11.3 years. The most common first symptoms in our patients were lower limb weakness, handgrip myotonia and limb pain, although some percentage of patients presented with cataracts or extrapyramidal symptoms and signs. Lens opacities were present in 75% of patients. Severe ECG abnormalities were noted in 8% and pacemaker was implanted in 5% of DM2 subjects. Pulmonary restriction was observed in 10% of DM2 patients. Insulin resistance and diabetes mellitus were frequent in our cohort (21% and 17%, respectively). Male subjects more frequently had snoring, baldness, sterility, polyneuropathy, lower HDL and higher glycaemia, while waddling gait and increased muscle reflexes were more common in females.
CONCLUSIONS: This registry offers a spectrum of different features presented in Serbian DM2 population, which could be at service of earlier diagnosis and better treatment.

Entities:  

Keywords:  Myotonic dystrophy type 2; cardiac conduction defects; cataracts; gender; registry

Mesh:

Year:  2018        PMID: 30248060     DOI: 10.3233/JND-180328

Source DB:  PubMed          Journal:  J Neuromuscul Dis


  4 in total

Review 1.  Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2.

Authors:  Andrea Romigi; Michelangelo Maestri; Carmine Nicoletta; Giuseppe Vitrani; Marco Caccamo; Gabriele Siciliano; Enrica Bonanni; Diego Centonze; Alessandro Sanduzzi
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

Review 2.  Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin.

Authors:  Tiago Mateus; Filipa Martins; Alexandra Nunes; Maria Teresa Herdeiro; Sandra Rebelo
Journal:  Int J Environ Res Public Health       Date:  2021-02-12       Impact factor: 3.390

3.  Fourier-Transform Infrared Spectroscopy as a Discriminatory Tool for Myotonic Dystrophy Type 1 Metabolism: A Pilot Study.

Authors:  Tiago Mateus; Idália Almeida; Adriana Costa; Diana Viegas; Sandra Magalhães; Filipa Martins; Maria Teresa Herdeiro; Odete A B da Cruz E Silva; Carla Fraga; Ivânia Alves; Alexandra Nunes; Sandra Rebelo
Journal:  Int J Environ Res Public Health       Date:  2021-04-06       Impact factor: 3.390

4.  Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2.

Authors:  Stojan Peric; Jelena Zlatar; Luka Nikolic; Vukan Ivanovic; Jovan Pesovic; Ivana Petrovic Djordjevic; Svetlana Sreckovic; Dusanka Savic-Pavicevic; Giovanni Meola; Vidosava Rakocevic-Stojanovic
Journal:  Front Neurol       Date:  2022-07-18       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.